Search research articles
Contact Us
Filters
Showing results (141-150 of 164) with videos related to
Page
of 17
Sort By:
Gut
|
December 1, 1978
Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma
S P Kane, I M Murray-Lyon, F J Paradinas, et al.
Journal of Medical Virology
|
August 1, 1993
Prevalence of hepatitis B, C, and D virus markers in Yemeni patients with chronic liver disease
A M el Guneid, A A Gunaid, A M O'Neill, et al.
Journal of Medical Virology
|
January 1, 1982
Non-A, non-B hepatitis: a case report
M Anderson, I M Murray-Lyon, J C Coleman, et al.
British Medical Journal (Clinical Research Ed.)
|
September 25, 1982
High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma
F J Paradinas, W M Melia, M L Wilkinson, et al.
Gut
|
October 1, 1975
Proceedings: Controlled trial of cysteamine and dimercaprol in the prevention of liver damage after paracetamol overdose
B G Gazzard, R D Hughes, A D Chhibber, et al.
British Journal of Urology
|
May 1, 1995
Khat chewing and bladder neck dysfunction. A randomized controlled trial of alpha 1-adrenergic blockade
A A Nasher, A A Qirbi, M A Ghafoor, et al.
Lancet (London, England)
|
July 25, 1970
Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs
I M Murray-Lyon, V A Parsons, L M Blendis, et al.
Journal of Medical Virology
|
December 1, 1985
Imported epidemic non-A, non-B hepatitis in Qatar
M J Glynn, A Rashid, A J Antao, et al.
The British Journal of Surgery
|
March 1, 1986
Strategy for lymph node biopsy in homosexual men suspected of having LAV/HTLV-III related disease
H J Scott, M J Glynn, I F Lane, et al.
Lancet (London, England)
|
November 21, 1981
Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain
L A Viola, I G Barrison, J C Coleman, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 164) with videos related to
Sort By:
Page
of 17
Gut
|
December 1, 1978
Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma
S P Kane, I M Murray-Lyon, F J Paradinas, et al.
Journal of Medical Virology
|
August 1, 1993
Prevalence of hepatitis B, C, and D virus markers in Yemeni patients with chronic liver disease
A M el Guneid, A A Gunaid, A M O'Neill, et al.
Journal of Medical Virology
|
January 1, 1982
Non-A, non-B hepatitis: a case report
M Anderson, I M Murray-Lyon, J C Coleman, et al.
British Medical Journal (Clinical Research Ed.)
|
September 25, 1982
High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma
F J Paradinas, W M Melia, M L Wilkinson, et al.
Gut
|
October 1, 1975
Proceedings: Controlled trial of cysteamine and dimercaprol in the prevention of liver damage after paracetamol overdose
B G Gazzard, R D Hughes, A D Chhibber, et al.
British Journal of Urology
|
May 1, 1995
Khat chewing and bladder neck dysfunction. A randomized controlled trial of alpha 1-adrenergic blockade
A A Nasher, A A Qirbi, M A Ghafoor, et al.
Lancet (London, England)
|
July 25, 1970
Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs
I M Murray-Lyon, V A Parsons, L M Blendis, et al.
Journal of Medical Virology
|
December 1, 1985
Imported epidemic non-A, non-B hepatitis in Qatar
M J Glynn, A Rashid, A J Antao, et al.
The British Journal of Surgery
|
March 1, 1986
Strategy for lymph node biopsy in homosexual men suspected of having LAV/HTLV-III related disease
H J Scott, M J Glynn, I F Lane, et al.
Lancet (London, England)
|
November 21, 1981
Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain
L A Viola, I G Barrison, J C Coleman, et al.
Page
of 17